NYSE · EVEX.WS

Eve Holding, Inc.. , each exercisable for one of at an exercise price of $11. 50 per

$0.15 +$0.02 (+16.45%) 1D Market open

Key Metrics

$46.00M
Market cap
P/E · TTM
Revenue · TTM
−$244.28M
Net income
EPS · TTM $-0.80
Dividend yield
Free cash flow −$216.28M
Beta · 1Y 2.94
EBITDA · TTM −$241.38M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 17
    From its Mar 5 high, the share price fell 73%.

    Peak close $0.45 on Mar 5; trough close $0.12 on Jul 17. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -73%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 9
    The stock moved -26.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 9
  • Jun 29
    The stock moved +30.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 29

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value−$87.34M
Shares outstanding
52-wk range$0.12 – $1.05
Avg volume · 20D20.6K
Net cash $133.34M
Book value / share$0.18
IndustryAircraft
ExchangeNYSE
About Eve Holding, Inc.. , each exercisable for one of at an exercise price of $11. 50 per
IPO dateMay 10, 2022
Employees198

Eve Holding Inc is a provider of Urban Air Mobility solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -271.5% · 316.1%

Financial Health

Current ratio3.80
Quick ratio
Debt / equity5.34
Debt / EBITDA -1.24
Net cash $133.34M
Working capital$336.42M

Cash Flow · TTM

Operating CF −$203.67M
Capex −$12.62M
Free cash flow −$216.28M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings